FES and pancreatic neoplasm: Recently, Nielsen et al. showed that neutrophils treated with conditioned medium from the pancreatic cancer cell line KPC mT4 and bone-marrow-derived neutrophils from the KPC mouse model with pancreatic tumors had increased non-receptor tyrosine kinase FES activity [233].